The warning letter issued by USFDA to large pharma companies more than
doubled in the first 10 months of 2019 compared with the previous
year, CRISIL said, adding that close to 180 generic drug launches will
be pushed out from their intended launch dates due to it.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/18-of-indian-pharma-launches-to-be-delayed-in-us-says-crisil/articleshow/73507475.cms
No comments:
Post a Comment